We are live on ! Find out more
ACM

Atlanta Capital Management Portfolio holdings

AUM $22.5B
1-Year Est. Return 9.67%
This Fund
S&P 500
This Quarter Est. Return
+2.76%
1 Year Est. Return
-9.67%
3 Year Est. Return
+30.19%
5 Year Est. Return
+88.74%
10 Year Est. Return
AUM
$15.1B
AUM Growth
+$98.4M
Cap. Flow
-$214M
Cap. Flow %
-1.42%
Top 10 Hldgs %
22.76%
Holding
164
New
10
Increased
42
Reduced
105
Closed
7

Top Sells

1
EFX icon
Equifax
EFX
+$210M
2
BIIB icon
Biogen
BIIB
+$63M
3
AAPL icon
Apple
AAPL
+$60.7M
4
MDT icon
Medtronic
MDT
+$44.7M
5
WST icon
West Pharmaceutical
WST
+$41.1M

Sector Composition

1 Technology 19.47%
2 Industrials 19.32%
3 Healthcare 17.65%
4 Financials 17.55%
5 Consumer Discretionary 10.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MKL icon
1
Markel Group
MKL
$24.6B
$466M 3.09%
502,107
+5,241
+1% +$4.89M
ANSS
2
DELISTED
Ansys
ANSS
$394M 2.61%
4,251,812
-34,256
-0.8% -$3.19M
SBH icon
3
Sally Beauty Holdings
SBH
$1.42B
$352M 2.34%
13,709,220
-74,247
-0.5% -$2.08M
IEX icon
4
IDEX
IEX
$16.7B
$343M 2.27%
3,660,986
-120,943
-3% -$10.9M
TFX icon
5
Teleflex
TFX
$5.94B
$327M 2.17%
1,946,661
+58,440
+3% +$10.5M
SEIC icon
6
SEI Investments
SEIC
$12B
$321M 2.13%
7,041,689
+776,855
+12% +$36.4M
XRAY icon
7
Dentsply Sirona
XRAY
$2.79B
$321M 2.13%
5,402,423
-244,977
-4% -$15.1M
FICO icon
8
Fair Isaac
FICO
$28.9B
$316M 2.1%
2,536,542
-227,049
-8% -$28.3M
BLKB icon
9
Blackbaud
BLKB
$1.49B
$298M 1.98%
4,488,453
-51,091
-1% -$3.46M
BIO icon
10
Bio-Rad Laboratories Class A
BIO
$8.11B
$294M 1.95%
1,793,796
+24,677
+1% +$3.75M
MANH icon
11
Manhattan Associates
MANH
$9.81B
$275M 1.83%
4,779,246
+519,767
+12% +$31.3M
AYI icon
12
Acuity Brands
AYI
$10B
$275M 1.83%
1,040,351
-6,039
-0.6% -$1.61M
AMG icon
13
Affiliated Managers Group
AMG
$9.78B
$273M 1.81%
1,889,057
+44,409
+2% +$6.36M
MORN icon
14
Morningstar
MORN
$6.53B
$265M 1.76%
3,343,318
-29,685
-0.9% -$2.44M
KEX icon
15
Kirby Corp
KEX
$7.66B
$257M 1.7%
4,133,752
+797,924
+24% +$45.8M
IDXX icon
16
Idexx Laboratories
IDXX
$44.4B
$252M 1.67%
2,231,311
-274,206
-11% -$28.9M
CLC
17
DELISTED
Clarcor
CLC
$247M 1.64%
3,804,580
-40,653
-1% -$2.57M
ATR icon
18
AptarGroup
ATR
$8.36B
$245M 1.63%
3,166,028
+44,120
+1% +$3.45M
WEX icon
19
WEX
WEX
$5.69B
$245M 1.63%
2,267,217
+239,273
+12% +$23.4M
JBHT icon
20
JB Hunt Transport Services
JBHT
$27.2B
$241M 1.6%
2,972,673
-15,402
-0.5% -$1.26M
CSL icon
21
Carlisle Companies
CSL
$14B
$241M 1.6%
2,346,119
-16,851
-0.7% -$1.76M
ARMK icon
22
Aramark
ARMK
$14.9B
$239M 1.58%
8,693,321
+6,318
+0.1% +$167K
COLM icon
23
Columbia Sportswear
COLM
$3.25B
$225M 1.5%
3,973,085
+658,207
+20% +$37.6M
JKHY icon
24
Jack Henry & Associates
JKHY
$10.7B
$218M 1.45%
2,547,694
-14,969
-0.6% -$1.31M
HSIC icon
25
Henry Schein
HSIC
$9.95B
$212M 1.41%
3,318,091
-65,654
-2% -$4.36M

Similar funds

Atlanta Capital Management's Q3 2016 Portfolio in Review

As of Q3 2016, Atlanta Capital Management held 164 positions worth $15.1B, up 0.66% from $15B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Atlanta Capital Management's Q3 2016 filing shows 10 new, 42 increased, 105 reduced and 7 closed positions. Its largest new stake was TransUnion: 3,718,402 shares worth $128M. The largest sale was Equifax, an estimated $210M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Industrials and Healthcare.

  • Atlanta Capital Management's largest Q3 2016 buy was TransUnion: 3,718,402 shares worth $128M.
  • Atlanta Capital Management added most to Kirby Corp in Q3 2016, an estimated $45.8M increase.
  • Atlanta Capital Management's biggest Q3 2016 reduction was Equifax, cutting an estimated $210M.
  • Atlanta Capital Management fully exited West Pharmaceutical in Q3 2016, selling an estimated $41.1M.
  • Atlanta Capital Management's ten largest holdings make up 23% of its $15.1B portfolio in Q3 2016.
  • Atlanta Capital Management opened 10 new positions and closed 7 in Q3 2016.
  • Atlanta Capital Management's portfolio value rose 0.66% quarter-over-quarter to $15.1B.

Based on Atlanta Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.